全文获取类型
收费全文 | 19578篇 |
免费 | 1256篇 |
国内免费 | 216篇 |
专业分类
耳鼻咽喉 | 256篇 |
儿科学 | 662篇 |
妇产科学 | 476篇 |
基础医学 | 2655篇 |
口腔科学 | 218篇 |
临床医学 | 1578篇 |
内科学 | 3709篇 |
皮肤病学 | 442篇 |
神经病学 | 1440篇 |
特种医学 | 608篇 |
外国民族医学 | 1篇 |
外科学 | 2486篇 |
综合类 | 476篇 |
一般理论 | 23篇 |
预防医学 | 3007篇 |
眼科学 | 489篇 |
药学 | 1129篇 |
2篇 | |
中国医学 | 138篇 |
肿瘤学 | 1255篇 |
出版年
2024年 | 29篇 |
2023年 | 186篇 |
2022年 | 357篇 |
2021年 | 636篇 |
2020年 | 292篇 |
2019年 | 539篇 |
2018年 | 650篇 |
2017年 | 444篇 |
2016年 | 478篇 |
2015年 | 557篇 |
2014年 | 741篇 |
2013年 | 1036篇 |
2012年 | 1494篇 |
2011年 | 1554篇 |
2010年 | 940篇 |
2009年 | 741篇 |
2008年 | 1126篇 |
2007年 | 1248篇 |
2006年 | 1172篇 |
2005年 | 969篇 |
2004年 | 913篇 |
2003年 | 860篇 |
2002年 | 742篇 |
2001年 | 378篇 |
2000年 | 333篇 |
1999年 | 269篇 |
1998年 | 113篇 |
1997年 | 101篇 |
1996年 | 79篇 |
1995年 | 77篇 |
1994年 | 74篇 |
1993年 | 49篇 |
1992年 | 166篇 |
1991年 | 154篇 |
1990年 | 167篇 |
1989年 | 186篇 |
1988年 | 162篇 |
1987年 | 161篇 |
1986年 | 131篇 |
1985年 | 118篇 |
1984年 | 84篇 |
1983年 | 65篇 |
1982年 | 24篇 |
1981年 | 32篇 |
1980年 | 25篇 |
1979年 | 48篇 |
1975年 | 32篇 |
1974年 | 25篇 |
1973年 | 25篇 |
1972年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Die Unfallchirurgie - 相似文献
102.
Wang Ben Deng Yu-xuan Yan Sha Xie Hong-fu Li Ji Jian Dan 《Lasers in medical science》2021,36(3):649-655
Lasers in Medical Science - Acne scarring is one of the most common facial skin disorders. The appropriate treatments for acne scars in patients with rosacea have not been studied. This study was... 相似文献
103.
104.
Amel Rezgui Maissa Thabet Sahar Makki Jihed Anoun Imen Ben Hassine Monia Karmeni Fatma Ben Fredj Anis Mzabi Chedia Laouani 《Reumatologia》2021,59(2):111
Coexistence of spondyloarthritis (SpA) and Takayasu’s arteritis is not a common finding, but such cases have been discussed, particularly in the context of choice of therapy. Inhibition of inflammation by tumor necrosis factor inhibitors (TNFi) is a key aspect of the treatment of SpA and also positive effects of such treatment in concomitant large vessel vasculitis have been reported. However, TNFi is also associated with the possibility of initiating vasculitis.The present article based on a case study and the available literature is an attempt to discuss coexistence of these two diseases and the impact of treatment with biological drugs from the anti-TNF group in the course of SpA with Takayasu’s arteritis. 相似文献
105.
106.
Tarek Debs Niccolo Petrucciani Sebastian Frey Carine Korkmaz Katharina Hufschmidt Eric Sejor Houssam Eddine Bitar Imed Ben Amor Antonio Iannelli Jean Gugenheim 《Surgery for obesity and related diseases》2021,17(5):901-908
BackgroundBariatric surgery has become widely performed for treating patients with morbid obesity, and the age limits are being pushed further and further as the procedure proves safe. After massive weight loss, many of those patients seek body-contouring surgery for excess skin and fat.ObjectivesTo analyze the feasibility and the safety of abdominoplasty in patients older than 55 years old after bariatric surgery.SettingUniversity hospital medical center.MethodsWe performed a retrospective review of prospectively collected data from patients aged older than 55 years who had undergone abdominoplasty following massive weight loss due to a bariatric surgery at a single institution from 2004 to 2017. The data analyzed included age, gender, preoperative body mass index, associated interventions, co-morbidities, and postoperative complications.ResultsWe retrieved records for 104 patients; 85.6% percent of them were female, and the mean age was 60.1 ± 3.9 years old. Of the 104 patients, 21 (20.2%) underwent a sleeve gastrectomy and 77 (74%) underwent a Roux-en-Y gastric bypass. The mean interval between the bariatric surgery and the abdominoplasty was 33.6 ± 26.9 months. The mean preoperative weight and body mass index were 76.1 ± 14.5 kg and 28.9 ± 4.5 kg/m2, respectively. A total complication rate of 20% was observed. The only factor significantly associated with postoperative morbidity was the associated procedure (P = .03), when we performed another procedure at the same time as the abdominoplasty. Complications included postoperative bleeding in 5 patients (4.8%), seromas in 5 patients (4.8%), surgical site infections in 12 patients (11.5%), and wound dehiscence or ischemia in 2 patients (1.9%). No mortality occurred.ConclusionAbdominoplasty can be safely performed in carefully selected patients older than 55 years old after weight loss surgery, and does not present increased morbidity or mortality. We recommend that surgeons avoid adding concomitant procedures when possible, to decrease the risk of complications. It is also important to look at the patient’s previous maximum BMI levels, as a higher maximum BMI can predict higher postoperative risks and longer hospital stays. 相似文献
107.
Chan Curtis Bavinton Benjamin R. Prestage Garrett E. Broady Timothy R. Mao Limin Rule John Wilcock Ben Holt Martin 《Archives of sexual behavior》2022,51(5):2509-2521
Archives of Sexual Behavior - Changes to how gay, bisexual, and other men who have sex with men (GBM) connect with each other and with their communities have implications for HIV prevention. Social... 相似文献
108.
109.
Kerri Viney Chris Lowbridge Fukushi Morishita Kalpeshsinh Rahevar Kyung H Oh Tauhid Islam Ben J Marais 《Bulletin of the World Health Organization》2021,99(5):330
ObjectiveTo assess the implementation of the Regional framework for action on implementation of the End TB Strategy in the Western Pacific, 2016–2020 in countries and areas in the World Health Organization Western Pacific Region.MethodsWe used a mixed methods approach to assess the framework’s measurable and perceived impact. We conducted an analysis of national tuberculosis strategic plans, a cross-sectional survey of senior staff of tuberculosis programmes, key informant interviews and some country case studies.FindingsOf the 37 countries and areas of the Western Pacific Region, 14 had a national tuberculosis strategic plan, including all countries and areas with a high incidence of tuberculosis. Most senior tuberculosis programme staff who responded to the survey (16/23) found the regional framework useful when developing their national targets and grant applications. Programmatic challenges identified included financing, human resources, public–private mix, active case finding, and paediatric and drug-resistant tuberculosis. Most of the 17 key informants thought that the regional framework’s categorization of actions (for all settings, for specific settings and for pre-elimination settings) was useful, but that the added value of the regional framework over other relevant documents was not obvious because of overlap in content.ConclusionThe regional framework influenced national level tuberculosis control planning and implementation in a positive way. A future regional framework should provide a longer-term strategic horizon and specifically address emerging trends and persistent problems faced by countries or areas of the region. 相似文献
110.
Louise B. Russell Sun-Young Kim Cristiana Toscano Ben Cosgriff Ruth Minamisava Ana Lucia Andrade Colin Sanderson Anushua Sinha 《Vaccine》2021,39(1):158-166
BackgroundThis paper compares cost-effectiveness results from two models of maternal immunization to prevent pertussis in infants in Brazil, one static, one dynamic, to explore when static models are adequate for public health decisions and when the extra effort required by dynamic models is worthwhile.MethodsWe defined two scenarios to explore key differences between static and dynamic models, herd immunity and time horizon. Scenario 1 evaluates the incremental cost/DALY of maternal acellular pertussis (aP) immunization as routine infant vaccination coverage ranges from low/moderate up to, and above, the threshold at which herd immunity begins to eliminate pertussis. Scenario 2 compares cost-effectiveness estimates over the models’ different time horizons. Maternal vaccine prices of $9.55/dose (base case) and $1/dose were evaluated.ResultsThe dynamic model shows that maternal immunization could be cost-saving as well as life-saving at low levels of infant vaccination coverage. When infant coverage reaches the threshold range (90–95%), it is expensive: the dynamic model estimates that maternal immunization costs $2 million/DALY at infant coverage > 95% and maternal vaccine price of $9.55/dose; at $1/dose, cost/DALY is $200,000. By contrast, the static model estimates costs/DALY only modestly higher at high than at low infant coverage. When the models’ estimates over their different time horizons are compared at infant coverage < 90–95%, their projections fall in the same range.ConclusionsStatic models may serve to explore an intervention’s cost-effectiveness against infectious disease: the direction and principal drivers of change were the same in both models. When, however, an intervention too small to have significant herd immunity effects itself, such as maternal aP immunization, takes place against a background of vaccination in the rest of the population, a dynamic model is crucial to accurate estimates of cost-effectiveness. This finding is particularly important in the context of widely varying routine infant vaccination rates globally.Clinical Trial registryClinical Trial registry name and registration number: Not applicable. 相似文献